Our findings were consistent with those from all the aforementioned Asian countries, where most of the germline pathogenic BRCA mutations in the Brunei breast cancer patients were identified in the BRCA2 gene compared to BRCA1 which was reported to be more affected in the European women [57]. This evidence concerns the gene BRCA1 and breast cancer.